Publications in collaboration with researchers from Sunnybrook Health Science Centre (16)

2022

  1. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement

    Canadian Journal of Cardiology, Vol. 38, Núm. 1, pp. 102-112

  2. Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation

    American Journal of Cardiology, Vol. 172, pp. 90-97

  3. Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 4, pp. 638-646

  4. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 79, Núm. 8, pp. 772-785

2021

  1. Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    Intensive Care Medicine

  2. Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189

    Annals of Oncology, Vol. 32, Núm. 7, pp. 881-895

  3. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  4. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Intensive Care Medicine, Vol. 47, Núm. 2, pp. 160-169

  5. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 18, pp. 2276-2287

  6. Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 11, pp. e3750-e3758

2020

  1. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    The Lancet Oncology, Vol. 21, Núm. 3, pp. 387-397

  2. Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 14, pp. 1505-1517

2018

  1. Emergency Heart Failure Mortality Risk Grade score performance for 7-day mortality prediction in patients with heart failure attended at the emergency department: Validation in a Spanish cohort

    European Journal of Emergency Medicine, Vol. 25, Núm. 3, pp. 169-177

  2. KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?

    Annals of Oncology, Vol. 29, pp. ix164

  3. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer

    New England Journal of Medicine, Vol. 378, Núm. 22, pp. 2078-2092

2017

  1. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation

    Journal of the American College of Cardiology, Vol. 70, Núm. 22, pp. 2752-2763